Shanghai MicuRx Pharmaceutical Co., Ltd.SSE: 688373

Shareholder's Inquiry Transfer Plan

Aug 22, 2025 · Issued by Shanghai MicuRx Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 22, 2025

On 6ix: 6ix.com/news/shareholders-inquiry-transfer-plan-65

Shareholder's Inquiry Transfer Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai MicuRx Pharmaceutical Co., Ltd. on 6ix

Earlier from Shanghai MicuRx Pharmaceutical

Announcement on Resignation and Appointment of Deputy General ManagerAug 20, 2025
Announcement on Continued Use of Idle Raised Funds Used for Cash ManagementAug 6, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Jul 18, 2025
Announcement on Change of Sponsor RepresentativeJul 16, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025Jul 2, 2025

Later from Shanghai MicuRx Pharmaceutical

Indicative Announcement on Pricing for Shareholder Inquiry TransferAug 23, 2025
Announcement on Voluntary Disclosure of the Approval of Marketing Registration for Contezolid API from New Additional ManufacturerSep 2, 2025
Report on the Transfer Result of Shareholders' Inquiry and Indicative Announcement on Change in Equity of Shareholder with Reaching 5% Shares Exceeding Integer Multiple of 5% and 1%Sep 5, 2025
Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025Sep 6, 2025
Announcement on Absence of Financial Assistance or Compensation Provided to the Investors in the Current Private Placement, Either Directly or Through Interested PartiesSep 23, 2025

All Shanghai MicuRx Pharmaceutical news releases

Follow Shanghai MicuRx Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai MicuRx Pharmaceutical